SpyGlass Pharma Inc. Common Stock
SGP | NASDAQ
$32.65
+$0.41 (+1.27%)
Nov 2, 2026, 10:36 AM ET · Market open
TTM Period Ending | TTM 2026 Jun 30, 2026 | TTM 2026 Mar 31, 2026 | TTM 2025 Dec 31, 2025 |
|---|---|---|---|
PE Ratio | -13.41 | -24.21 | -21.12 |
PEG Ratio | 0.93 | -0.30 | n/a |
PS Ratio | n/a | n/a | n/a |
PB Ratio | 3.20 | 2.06 | -8.52 |
P/FCF Ratio | -14.97 | -15.66 | -25.16 |
P/OCF Ratio | -15.99 | -16.28 | -25.76 |
OCF/S Ratio | n/a | n/a | n/a |
Debt / Equity Ratio | 0.01 | 0.01 | -0.02 |
Quick Ratio | 25.06 | 38 | 12.67 |
Current Ratio | 25.06 | 38 | 12.67 |
Asset Turnover | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a |
Return on Equity | -75.64% | -169.50% | 40.34% |
Return on Assets | -23.03% | -14.01% | -34.41% |
Return on Invested Capital | -20.97% | -12.60% | -38.64% |
Dividend Yield | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove SGP